Acorda is down 6%, Auxilium is down 35%, Dendreon is down 27%, and Momenta is down 30%.

FORBES: Biotech, Where Winners Lose

The motion was brought by Novartis and Momenta Pharmaceuticals, who are seeking to launch a generic version.

FORBES: Teva Wins Copaxone Protection

Momenta's chief executive, Craig Wheeler, said the company had no comment, and hoped to soon review the SEC complaint.

WSJ: FDA Chemist Charged With Insider Trading

Another of the companies whose stock he allegedly traded was Momenta Pharmaceuticals Inc.

WSJ: FDA Chemist Charged With Insider Trading

In a three-day stretch in mid-January, the writer saw five concerts by four groups the JACK Quartet, the Momenta Quartet, the Danish Quartet, and an unnamed Juilliard foursome.

NEWYORKER: The Power of Four

Novartis and Momenta alleged that the lack of information about the molecular weight of the molecules rendered the patents unenforceable, according to a note to investors by Sanford C.

FORBES: Teva Wins Copaxone Protection

Momenta Senior Vice President StevenBruggerSteven Brugger says such copies won't be nearly as cheap, because there will be fewer companies able to make them and create competition and drive down prices.

FORBES: Magazine Article

The writer saw the Momenta Quartet at the HiArt!

NEWYORKER: The Power of Four

Momenta Senior Vice President Steven Brugger says such copies won't be nearly as cheap, because there will be fewer companies able to make them and create competition and drive down prices.

FORBES: Nagging Doubts For Big Pharma

Indeed, in the graveyard of failed technology products, the pen computing section is overrun with tombstones - GRiDPad, Zoomer, PenWindows, Momenta, CreuisePAD, Newton, Envoy, Marco, Magic Link, EO, Avigo, Clie, CrossPad, TransNote, Clio, Qbe, Audrey, and Smart Display, to name a few.

ENGADGET: Switched On: Time to write off pen computing